Switching to systemic janus kinase inhibitors following dupilumab failure for atopic dermatitis: an evidence-based review

被引：0
|
作者：
Sood, S. [1 ]
Bagit, A. [1 ]
Heung, M. [2 ]
Maliyar, K. [3 ]
Abduelmula, A. [3 ]
Sachdeva, M. [3 ]
Georgakopoulos, J. [3 ]
Mufti, A. [3 ,4 ]
Prajapati, V. [5 ,6 ,7 ,8 ,9 ,10 ]
Yeung, J. [3 ,4 ,10 ,11 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada
[3] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[5] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada
[6] Dermatol Res Inst, Calgary, AB, Canada
[7] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[8] Univ Calgary, Sect Community Pediat, Dept Pediat, Calgary, AB, Canada
[9] Univ Calgary, Sect Pediat Rheumatol, Dept Pediat, Calgary, AB, Canada
[10] Prob Med Res, Waterloo, ON, Canada
[11] Womens Coll Hosp, Dept Dermatol, Toronto, ON, Canada
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
37
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [1] Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review
    Sood, Siddhartha
    Bagit, Ahmed
    Heung, Martin
    Maliyar, Khalad
    Abduelmula, Abrabim
    Sachdeva, Muskaan
    Georgakopoulos, Jorge R.
    Mufti, Asfandyar
    Prajapati, Vimal H.
    Yeung, Jensen
    [J]. JAAD INTERNATIONAL, 2024, 16 : 31 - 33
  • [2] Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
    Eshtiaghi, Panteha
    Gooderham, Melinda J.
    [J]. CORE EVIDENCE, 2018, 13 : 13 - 20
  • [3] Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications
    Chang, Po-Hsiung
    Huang, Sheng-Fen
    Chang, Po-Sheng
    Yu, Yu
    [J]. JOURNAL OF DERMATOLOGY, 2021, 48 (11): : 1631 - 1639
  • [4] Janus kinase inhibitors for the therapy of atopic dermatitis
    Traidl, S.
    Freimooser, S.
    Werfel, T.
    [J]. ALLERGOLOGIE, 2021, 44 (09) : 710 - 723
  • [5] Oral Janus kinase inhibitors for atopic dermatitis
    Mikhaylov, Daniela
    Ungar, Benjamin
    Renert-Yuval, Yael
    Guttman-Yassky, Emma
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (05) : 577 - 592
  • [6] Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study)
    Reguiai, Ziad
    Becherel, Pierre Andre
    Perrot, Jean Luc
    Boulard, Claire
    Fougerousse, Anne Claire
    Begon, Edouard
    Badaoui, Antoine
    Poreaux, Claire
    Parier, Josiane
    Liegeon, Anne-Laure
    Levavasseur, Matthieu
    Bing, Anne-Claire
    Esteve, Eric
    Maccari, Francois
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [7] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1923 - 1933
  • [8] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
    Carlos Alves
    Ana Penedones
    Diogo Mendes
    Francisco Batel Marques
    [J]. European Journal of Clinical Pharmacology, 2022, 78 : 1923 - 1933
  • [9] The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review
    Abduelmula, Abrahim
    Bagit, Ahmed
    Mufti, Asfandyar
    Yeung, Katie C. Y.
    Yeung, Jensen
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2023, 27 (03) : 271 - 276
  • [10] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives
    Munera-Campos, M.
    Carrascosa, J. M.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2023, 114 (08): : 680 - 707
12345